Characteristics of 33 patients with lymphoblastic lymphoma
Characteristic . | No. (%) . |
|---|---|
| 25 y or older | 20 (61) |
| Male | 27 (82) |
| SVC syndrome | 2 (6) |
| Mediastinal disease | 23 (70) |
| Effusions | |
| Pleural | 10 (30) |
| Pericardial | 3 (9) |
| Adenopathy | |
| Cervical | 8 (24) |
| Other | 6 (18) |
| CNS disease at presentation | 3 (9) |
| Skin involvement | 3 (9) |
| Marrow involvement, 6% to 25% blasts | 5 (15) |
| Ann Arbor stage | |
| I/II | 10 (30) |
| III/IV | 23 (70) |
| Hemoglobin below 120 g/L | 10 (30) |
| LDH IU/L more than twice ULN | 8 (24) |
| β2 microglobulin, mg % (n = 30) | |
| 3 or higher | 3 (9) |
| B symptoms | 10 (30) |
| Immunophenotype (n = 32) | |
| T cell | 26 (79) |
| B cell | 6 (18) |
Characteristic . | No. (%) . |
|---|---|
| 25 y or older | 20 (61) |
| Male | 27 (82) |
| SVC syndrome | 2 (6) |
| Mediastinal disease | 23 (70) |
| Effusions | |
| Pleural | 10 (30) |
| Pericardial | 3 (9) |
| Adenopathy | |
| Cervical | 8 (24) |
| Other | 6 (18) |
| CNS disease at presentation | 3 (9) |
| Skin involvement | 3 (9) |
| Marrow involvement, 6% to 25% blasts | 5 (15) |
| Ann Arbor stage | |
| I/II | 10 (30) |
| III/IV | 23 (70) |
| Hemoglobin below 120 g/L | 10 (30) |
| LDH IU/L more than twice ULN | 8 (24) |
| β2 microglobulin, mg % (n = 30) | |
| 3 or higher | 3 (9) |
| B symptoms | 10 (30) |
| Immunophenotype (n = 32) | |
| T cell | 26 (79) |
| B cell | 6 (18) |
No patients had clinically significant hepatosplenomegaly at presentation. SVC indicates superior vena cava syndrome; LDH, lactate dehydrogenase; ULN, upper limit normal; and B symptoms, tumor fever higher than 38°C, night sweats, and/or weight loss more than 10%.